Related references
Note: Only part of the references are listed.Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells
G. Wang et al.
CELL DEATH AND DIFFERENTIATION (2012)
Mechanisms of Disease: Hypoxia and Inflammation.
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1α Expression in MCF-7 Breast Cancer Cells
Jun Du et al.
PLOS ONE (2011)
Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
Bernhard Kloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PI3K/AKT/mTOR pathway in angiogenesis
Jayashree Karar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Kristina M. Cook et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells
Tao Tian et al.
CARCINOGENESIS (2010)
p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN
Deborah H. Anderson
CELL CYCLE (2010)
Antiangiogenesis agents in colorectal cancer
Joleen Hubbard et al.
CURRENT OPINION IN ONCOLOGY (2010)
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
Thomas Winder et al.
GASTROENTEROLOGY (2010)
Anti-Angiogenic Therapy: Adapting Strategies to Overcome Resistant Tumors
Dianne C. Mitchell et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability
Magdalena Skrzypczak et al.
PLOS ONE (2010)
Activity of any class IA PI3K isoform can sustain cell proliferation and survival
Lazaros C. Foukas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Tom D. Bunney et al.
NATURE REVIEWS CANCER (2010)
PI3K Regulatory Subunits Lose Control in Cancer
Inma Martin-Berenjeno et al.
CANCER CELL (2009)
Activation of HIF-1 alpha in Exponentially Growing Cells Via Hypoxic Stimulation Is Independent of the Akt/mTOR Pathway
Frederic Dayan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Axel Grothey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Regulation of hypoxia-inducible factor-1α by NF-κB
Patrick van Uden et al.
BIOCHEMICAL JOURNAL (2008)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Angiogenesis in pre-malignant conditions
S. R. Menakuru et al.
BRITISH JOURNAL OF CANCER (2008)
Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1α by MAPK
Ilias Mylonis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy
Junbo Hu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
PTEN-deficient cancers depend on PIK3CB
Susan Wee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
Jing Fang et al.
CELLULAR SIGNALLING (2007)
Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer
Lin Zhang et al.
CLINICAL CANCER RESEARCH (2007)
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
K Hamada et al.
GENES & DEVELOPMENT (2005)
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
T Lawrence et al.
NATURE (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor
T Pufe et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest
XM Xia et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
